FDA approves drug aimed at preventing migraines

FDA approves drug aimed at preventing migraines

This image provided by Amgen Inc. shows an artist’s rendering of the packaging for the drug Aimovig.(Photo: AP) The U.S. Food and Drug Administration has approved the first drug aimed at preventing migraine headaches. The drug, Aimovig, is taken by patients once a month through self-injection. The drug blocks a key molecule involved in sparking migraine […]

FDA Drug Safety Communication: FDA to evaluate potential risk of neural tube birth defects with HIV medicine …

FDA Drug Safety Communication: FDA to evaluate potential risk of neural tube birth defects with HIV medicine …

FREE Breaking News Alerts from StreetInsider.com! StreetInsider.com Top Tickers, 5/18/2018 May 18, 2018 10:44 AM EDT Tweet Send to a Friend The U.S. Food and Drug Administration (FDA) is alerting the public that serious cases of neural tube birth defects involving … This is a premium only article. To continue reading this article and more […]

Cure for Migraine? FDA Approves Amgen, Novartis Drug Aimovig

Cure for Migraine? FDA Approves Amgen, Novartis Drug Aimovig

The FDA has approved a new migraine drug that can cut the number of attacks patients suffer each month.  The drug, called erenumab-aooe and marketed as Aimovig, is the first preventative migraine treatment approved by the FDA, according to a statement from the body.  Aimovig is one of a new type of drug that blocks the molecule […]

FDA approves new drug that could change the way doctors treat migraine sufferers

FDA approves new drug that could change the way doctors treat migraine sufferers

TRENTON, N.J. — U.S. regulators Thursday approved the first drug designed to prevent chronic migraines. The Food and Drug Administration’s action clears the monthly shot Aimovig (AIM’-oh-vig) for sale. It’s the first in a new class of long-acting drugs for preventing migraines. Three other shots are expected to win approval by next year, and several […]

FDA approves Amgen drug for prevention of migraines

FDA approves Amgen drug for prevention of migraines

(Corrects to $10,000 a year instead of $10,000 a month, paragraph 3) By Deena Beasley May 17 (Reuters) – Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults. The drug, Aimovig, which is given monthly by self-injection, will […]